Next Article in Journal
Role of Diuretics and Ultrafiltration in Congestive Heart Failure
Next Article in Special Issue
Characterization of Antimicrobial Peptides toward the Development of Novel Antibiotics
Previous Article in Journal
Current Challenges and Future Directions in Recombinant AAV-Mediated Gene Therapy of Duchenne Muscular Dystrophy
Pharmaceuticals 2013, 6(7), 837-850; doi:10.3390/ph6070837
Article

Diamidines versus Monoamidines as Anti-Pneumocystis Agents: An in Vivo Study

1
, 2
, 2
, 3
, 1
, 4
, 4
, 1,* , 2
, 2,5 and 2
Received: 22 April 2013; in revised form: 14 May 2013 / Accepted: 17 June 2013 / Published: 1 July 2013
(This article belongs to the Special Issue Antimicrobial Agents)
View Full-Text   |   Download PDF [428 KB, updated 3 July 2013; original version uploaded 1 July 2013]   |   Browse Figures
Abstract: Some compounds articulated around a piperazine or an ethylenediamine linker have been evaluated in vitro to determine their activity in the presence of a 3T6 fibroblast cell line and an axenic culture of Pneumocystis carinii, respectively. The most efficient antifungal derivatives, namely N,N′-bis(benzamidine-4-yl)ethane-1,2-diamine (compound 6, a diamidine) and N-(benzamidine-4-yl)-N′-phenylethane-1,2-diamine (compound 7, a monoamidine), exhibited no cytotoxicity and were evaluated in vivo in a rat model. Only the diamidine 6 emerged as a promising hit for further studies.
Keywords: Pneumocystis; pentamidine; diamidine Pneumocystis; pentamidine; diamidine
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Export to BibTeX |
EndNote


MDPI and ACS Style

Stanicki, D.; Pottier, M.; Gantois, N.; Pinçon, C.; Forge, D.; Mahieu, I.; Boutry, S.; Eynde, J.J.V.; Martinez, A.; Dei-Cas, E.; Aliouat, E.-M. Diamidines versus Monoamidines as Anti-Pneumocystis Agents: An in Vivo Study. Pharmaceuticals 2013, 6, 837-850.

AMA Style

Stanicki D, Pottier M, Gantois N, Pinçon C, Forge D, Mahieu I, Boutry S, Eynde JJV, Martinez A, Dei-Cas E, Aliouat E-M. Diamidines versus Monoamidines as Anti-Pneumocystis Agents: An in Vivo Study. Pharmaceuticals. 2013; 6(7):837-850.

Chicago/Turabian Style

Stanicki, Dimitri; Pottier, Muriel; Gantois, Nausicaa; Pinçon, Claire; Forge, Delphine; Mahieu, Isabelle; Boutry, Sébastien; Eynde, Jean J.V.; Martinez, Anna; Dei-Cas, Eduardo; Aliouat, El-Moukhtar. 2013. "Diamidines versus Monoamidines as Anti-Pneumocystis Agents: An in Vivo Study." Pharmaceuticals 6, no. 7: 837-850.


Pharmaceuticals EISSN 1424-8247 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert